"At GenesisCare, we’re designing better care. We’re bringing together our skills, knowledge, and empathy to develop a detailed understanding of your needs, so we can design the right care plan for you if you’re receiving treatment for heart disease or cancer. We provide a comprehensive cardiology service using the latest equipment and techniques to provide consistent, high-quality treatment. We bring together cardiology experts, the latest diagnostic cardiac testing and cardiac procedures to ensure each person with cardiovascular disease has the best possible outcome. We offer accessible, affordable, efficient and high-quality cardiology services wherever it is needed."

During the past decade, HeartCare Partners Clinical Research Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "HeartCare Partners Clinical Research Unit" #1 collaborator was "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "HeartCare Partners Clinical Research Unit" are "Cardiovascular Disease" (1 trials), "High Cardiovascular Risk" (1 trials), "Obesity" (1 trials), "Overweight" (1 trials) and "Recurrent Pericarditis" (1 trials). Many other conditions were trialed in "HeartCare Partners Clinical Research Unit" in a lesser frequency.

Most popular intervention types in "HeartCare Partners Clinical Research Unit" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Lorcaserin hydrochloride" (1 trials) and "Rilonacept" (1 trials). Other intervention names were less common.

The vast majority of trials in "HeartCare Partners Clinical Research Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "HeartCare Partners Clinical Research Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in HeartCare Partners Clinical Research Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HeartCare Partners Clinical Research Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".